McKesson (MCK) Stock Price, News & Analysis

Company Overview

McKesson Corporation is a leading global healthcare services and pharmaceutical distribution company. It provides essential products and services that help pharmacies, hospitals and healthcare providers manage the commercial supply chain for pharmaceuticals and medical devices. The company’s offerings span brand-name and generic drugs, biologics, vaccines, over-the-counter remedies and specialty pharmaceuticals. McKesson also supports patient care through technology solutions designed to optimize clinical workflows and supply chain operations.

The firm operates through two primary segments: pharmaceutical distribution and medical-surgical distribution. Its pharmaceutical distribution network supplies medicines and specialty therapies to retail pharmacies, hospital systems and physician practices. The medical-surgical segment delivers a broad portfolio of medical supplies, laboratory products and care management software to acute care facilities. Beyond distribution, McKesson offers pharmacy automation, electronic health records, data analytics platforms and revenue cycle management tools that aim to improve operational efficiency and clinical outcomes.

Headquartered in Irving, Texas, McKesson serves customers across North America, Europe and the Asia-Pacific region. Regional hubs in Canada, the United Kingdom, Ireland, Germany and China enable the company to navigate local regulations and market dynamics effectively. McKesson’s extensive logistics infrastructure encompasses more than 100 distribution centers, a fleet of temperature-controlled vehicles and integrated delivery networks to ensure timely fulfillment and product integrity.

Founded in 1833 as John McKesson & Robbins, the company evolved from a small retail pharmacy into one of the world’s largest healthcare distributors. Over its history, strategic acquisitions—such as the integration of Change Healthcare—have broadened its technology, analytics and specialty distribution capabilities. Under the leadership of President and Chief Executive Officer Brian Tyler, McKesson continues to prioritize innovation, patient safety and value-based care partnerships to support a rapidly changing healthcare landscape.

Key Stats

• Today's Range: $706.10 to $710.79
• 50-Day Range: $682.20 to $735.41
• 52-Week Range: $464.42 to $737.89
• Volume: 530,634 shs
• Average Volume: 926,972 shs
• Market Capitalization: $88.64 billion
• P/E Ratio: 27.43
• Dividend Yield: 0.40%
• Price Target: $706.83
• Consensus Rating: Moderate Buy

McKesson Stock Analysis - MarketRank™

McKesson scored higher than 92% of companies evaluated by MarketBeat, and ranked 66th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

McKesson has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 10 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

McKesson has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 11.81%

Earnings Growth

Earnings for McKesson are expected to grow by 11.81% in the coming year, from $32.77 to $36.64 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of McKesson is 27.43, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.87.

Price to Earnings Ratio vs. Sector

The P/E ratio of McKesson is 27.43, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.46.

Price to Earnings Growth Ratio

McKesson has a PEG Ratio of 1.45. PEG Ratios above 1 indicate that a company could be overvalued.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.71% of the float of McKesson has been sold short.

Short Interest Ratio / Days to Cover

McKesson has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in McKesson has recently increased by 5.97%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

McKesson has a dividend yield of 0.39%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

McKesson has been increasing its dividend for 17 years.

Dividend Coverage

The dividend payout ratio of McKesson is 10.99%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, McKesson will have a dividend payout ratio of 7.75% next year. This indicates that McKesson will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.0 / 5
• Environmental Score: -1.01

Percentage of Shares Shorted

1.71% of the float of McKesson has been sold short.

Short Interest Ratio / Days to Cover

McKesson has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in McKesson has recently increased by 5.97%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 1.02

News Sentiment

McKesson has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 42 news articles for McKesson this week, compared to 28 articles on an average week.

Search Interest

Only 16 people have searched for MCK on MarketBeat in the last 30 days. This is a decrease of -16% compared to the previous 30 days.

MarketBeat Follows

Only 5 people have added McKesson to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, McKesson insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,526,451.00 in company stock.

Percentage Held by Insiders

Only 0.08% of the stock of McKesson is held by insiders.

Percentage Held by Institutions

85.07% of the stock of McKesson is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MCK Stock Analysis - Frequently Asked Questions

How have MCK shares performed this year?

McKesson's stock was trading at $569.91 at the beginning of 2025. Since then, MCK shares have increased by 24.3% and is now trading at $708.4940.

How were McKesson's earnings last quarter?

McKesson Corporation (NYSE:MCK) announced its quarterly earnings results on Thursday, May, 8th. The company reported $10.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.83 by $0.29. The company's revenue was up 18.9% on a year-over-year basis.
Read the conference call transcript.

Does McKesson have any subsidiaries?

McKesson subsidiaries include Echo, LloydsDirect, Medical Specialties Distributors, Well.ca, RxCrossroads, CoverMyMeds, HealthQx, and more.

Who are McKesson's major shareholders?

Top institutional investors of McKesson include Swedbank AB (0.48%), Assenagon Asset Management S.A. (0.25%), Wealth Enhancement Advisory Services LLC (0.15%) and Alecta Tjanstepension Omsesidigt (0.11%). Insiders that own company stock include Brian S Tyler, Britt J Vitalone, Nancy Avila, Lori A Schechter, Leann B Smith, Thomas L Rodgers, Napoleon B Rutledge Jr, Tracy Faber, Susan R Salka and Maria Martinez.
View institutional ownership trends.

How do I buy shares of McKesson?

Shares of MCK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some other companies that McKesson investors own include Comcast (CMCSA), Chevron (CVX), Bristol Myers Squibb (BMY), Charles Schwab (SCHW), Edwards Lifesciences (EW), Yum! Brands (YUM) and Toronto Dominion Bank (TD).

Company Calendar

• Last Earnings: 5/08/2025
• Record date for 7/1 Dividend: 6/02/2025
• Ex-Dividend for 7/1 Dividend: 6/02/2025
• Dividend Payable: 7/01/2025
• Today: 7/11/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Health Care Distributors
• Current Symbol: NYSE:MCK
• CIK: 927653
• Web: www.mckesson.com
• Phone: (972) 446-4800
• Fax: 415-983-8453
• Employees: 45,000
• Year Founded: 1833

Price Target and Rating

• Average Price Target for McKesson: $706.83
• High Price Target: $805.00
• Low Price Target: $579.00
• Potential Upside/Downside: -0.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.86
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): $25.83
• Trailing P/E Ratio: 27.47
• Forward P/E Ratio: 21.67
• P/E Growth: 1.45
• Net Income: $3.30 billion
• Net Margins: 0.92%
• Pretax Margin: 1.21%
• Return on Equity: -201.12%
• Return on Assets: 5.83%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.90
• Quick Ratio: 0.53

Sales & Book Value

• Annual Sales: $359.05 billion
• Price / Sales: 0.25
• Cash Flow: $37.93 per share
• Price / Cash Flow: 18.72
• Book Value: ($13.52) per share
• Price / Book: -52.53

Miscellaneous

• Outstanding Shares: 125,110,000
• Free Float: 125,012,000
• Market Cap: $88.85 billion
• Optionable: Optionable
• Beta: 0.48